enzh-TWfrdeitjaptrues

Date: March 12, 2011 Location: 4th International Patient & Physician Summit on WM, Orlando, FL
Lecturer: Karen Lee Sobol Subject: Twelve Weeks, An Artists Story of Cancer, Healing, and Hope

Karen Lee Sobol shares her personal insights and experiences, and provides a patient's perspective on the research and treatment of Waldenstrom's Macroglobulinemia.

Click video player to start video. NOTE: It may take a few minutes for video to load.

 

Latest Bing Center News

Dana-Farber Researchers Use Machine Learning to Understand Rare Familial Blood Cancer

Dana-Farber Researchers Use Machine Learning to Understand Rare Familial Blood Cancer

Researchers at Dana-Farber have put together a data atlas that includes a range of genomic, transcriptomic, epigenetic, and clinical data from patients and healthy donors to try to understand familial WM.

Read more..

Topics from the 11th IWWM Workshop in Madrid

Topics from the 11th IWWM Workshop in Madrid

Bing Center WM experts discuss various topics from the 11th IWWM in Madrid.

Read more..

Expert Advice for Newly Diagnosed Waldenström Macroglobulinemia (WM) Patients

Expert Advice for Newly Diagnosed Waldenström Macroglobulinemia (WM) Patients

What should you know if you or a loved one has been diagnosed with Waldenström macroglobulinemia (WM)? Dr. Shayna Sarosiek of the Dana-Farber Cancer Institute shares key advice.

Read more..

Talking with your Waldenstrom's Macroglobulinemia Patients

Talking with your Waldenstrom's Macroglobulinemia Patients

This document, written by Drs. Jorge Castillo and Shayna Sarosiek, provides a reference guide to assist medical professionals in discussions with WM patients. Patients can give this booklet to their PCP, oncologist, or other health care provider in order to help familiarize them with this uncommon disease.

Read more..

2022 ASH Conference Report: Waldenstrom Macroglobulinemia

2022 ASH Conference Report: Waldenstrom Macroglobulinemia

From the 64th ASH Annual Meeting, Jorge Castillo, MD, Clinical Director of the Bing Center for Waldenström’s Macroglobulinemia at Dana-Farber Cancer Institute in Boston, updates our Waldenström patient community on important research results presented this year, offers guidance on finding relevant clinical trials, and highlights what to look for in the coming year.

Read more..

RECORDING AVAILABLE - Treatment, Trials, and Hope-For ALL Stages of Disease

RECORDING AVAILABLE - Treatment, Trials, and Hope-For ALL Stages of Disease

RECORDING NOW AVIALABLE! Join IWMF on ZOOM for this very important topic that affects everyone with a WM diagnosis! Dr. Jorge Castillo presents - Treatments, Trials, and Hope – for ALL Stages of Disease. Dr. Castillo is a GLOBAL SPECIALIST IN Waldenstrom's Macroglobulinemia (WM) AND Clinical Director of the Bing Center Clinic (for WM) at Dana-Farber Cancer Institute.

Read more..

Everything You Want to Know About BTK Inhibitors, Do's and Don'ts

Everything You Want to Know About BTK Inhibitors, Do's and Don'ts

With so many patients choosing BTK inhibitors for their Waldenstrom Macroglobulinemia treatment, and new WM treatments in development, it is difficult to keep up with so much new information. This is your chance to get Dr. Jorge Castillo's expert info about BTK inhibitors, long term goals and monitoring; what to do, what not to do; complications; and even some success stories.

Read more..

Bing Center Researchers Awarded Over $1M in Funding From IWMF

Bing Center Researchers Awarded Over $1M in Funding From IWMF

IWMF grant funding for research projects has helped to provide an understanding of the basic biology and genetics of WM. This research in turn has played a significant role in the development of treatments and treatment guidelines in current use, as well as potential new drugs still in the pipeline. The goal of our research program is to improve quality of life for WM patients and, ultimately, discover a cure.

Read more..

Diagnosis and Management of Waldenstrom’s Macroglobulinemia

Diagnosis and Management of Waldenstrom’s Macroglobulinemia

Waldenstrom’s macroglobulinemia (WM) is a rare type of cancer that begins in the white blood cells.The abnormal white blood cells produce a protein that accumulates in the blood, impairs circulation and causes complications. It continues to be a clinical challenge for treating physicians as complete remissions and prevention of relapse are few in spite of all the therapeutic tools that are currently available.  Besides treatment aspects, correct diagnosis of WM often poses a challenge.

Read more..

U.S. News & World Report Names Dana-Farber Brigham Cancer Center among nation's best for 2022-2023

U.S. News & World Report Names Dana-Farber Brigham Cancer Center among nation's best for 2022-2023

For the 22nd consecutive year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by U.S. News & World Report. This year, Dana-Farber Brigham Cancer Center is ranked as the best hospital for cancer care in New England and #4 in the nation.

Read more..